Anthropic IPO Plans Face AI Backlash and Data-Center Risks

Anthropic is preparing a potential initial public offering (IPO) that could seek a public valuation or float of around $2 trillion and raise more than $100 billion, potentially surpassing SpaceX’s records, while its prospectus is expected to identify artificial intelligence (AI) backlash and data-center constraints as risks. CNBC reported that Anthropic filed confidentially in June and held preliminary meetings with bankers and investors in San Francisco, with the filing expected within weeks; other reporting has suggested a listing potentially as soon as fall 2026. The company’s private-market valuation is nearly $1 trillion, including a reported $900 billion valuation in a funding round this year, while its annualized revenue jumped to more than $65 billion last month and second-quarter revenue reached $11.6 billion. Chief Financial Officer Krishna Rao is addressing investor concerns about competition, margin pressure from open-source or open-weight models and slower data-center construction, because compute capacity is closely tied to AI-lab revenue. Public opposition is rising: a March Gallup survey found that 7 in 10 Americans opposed a local AI data center, including 48% strongly opposed; an August 8-13 Heatmap Pro poll of 2,045 registered voters by Embold Research found opposition at 75%, up from 42% a year earlier; and Pew Research found that 71% of adults expected AI to reduce U.S. jobs over the next two decades, compared with 64% in 2024. Pennsylvania Governor Josh Shapiro imposed strict data-center development standards, while New York Governor Kathy Hochul paused permits for large new data centers. Anthropic was founded in 2021 by Chief Executive Officer Dario Amodei, his sister Daniela and former OpenAI employees, and has expanded through Claude Code and enterprise demand. Amodei’s wife, Cami Clark, has no formal title, salary or equity at Anthropic but acted as an informal strategic adviser and helped connect the company with former Google CEO Eric Schmidt, whose participation contributed to its $124 million Series A, closed in May 2021. President Trump separately discussed AI-enabled medical innovation and an unnamed "pretty unstoppable disease" without identifying Anthropic or providing evidence linking his remarks to the company.

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.